Overall Technical outlook

Price Summary

2025-09-05, saw AJANTPHARM's stock open at 2575.2, hit a peak of 2627.5, fall to a low of 2566.2, and close higher 1.51% at 2614.1, with 102989 shares changing hands.
For the 52-week period, the stock's highest price is 3426.5, and the lowest price is 2374.45.
Analysts expect the price of AJANTPHARM to vary between 2307.0 and 3293.0, with an average expected price near 3008.3333.

Technicals

Support and Resistance: At 2614.1, the price for AJANTPHARM is supported at 2508.1 and resisted at 2617.4. This indicates a trading range where 2508.1 serves as a support level, potentially preventing further decline, while 2617.4 could limit upward movement.
AJANTPHARM supportResistance 03f2db
Support/Resistance for AJANTPHARM


Aroon: The AROON is in a neutral stance for AJANTPHARM, not indicating a clear upward or downward trend. This suggests a period of market indecision, where neither bulls nor bears have the upper hand.
AJANTPHARM aroon 03f2db
Aroon chart for Ajanta Pharma Limited


Bol. Bands: The current reading of the BOLL BANDS is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
AJANTPHARM bbands 03f2db
Bolinger Bands chart for Ajanta Pharma Limited


Parabolic SAR: The PSAR for AJANTPHARM continues to indicate a bearish outlook, reinforcing a resistance level that could limit upward potential. This suggests that the market may remain under bearish control, with resistance acting as a barrier to significant upward movement.
AJANTPHARM psar 03f2db
Parabolic Stop and Reverse chart for Ajanta Pharma Limited


Stochastic: The STOCHASTIC is in a neutral stance, with no clear direction indicated for the market. This lack of clarity suggests that the market may be in a state of equilibrium for AJANTPHARM, with no strong trend emerging.
AJANTPHARM stoch 03f2db
Stochastic chart for Ajanta Pharma Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently neutral, offering no clear guidance on market direction. This suggests that the market may be in a state of pause, with no strong trend emerging.
AJANTPHARM trippleSMA 03f2db
Tripple SMA chart for Ajanta Pharma Limited


When evaluating a company's technical indicators like price trends and trading volume, it's important to also assess its fundamentals. Key factors include the company's profitability, growth rate, and financial stability. Furthermore, considering the industry within which the company operates provides additional context, as factors like competition and market demand can affect performance. By combining this analysis, you can make more informed judgments about the company's future prospects.